News

Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Discusses Therapeutic Benefits of Cannabis During Annual International League Against Epilepsy Meeting

July 28, 2017

general-hemp-blog-rsho-x-11-28-16-ver1

SAN DIEGO, July 27, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Mexico participated in the LX Annual Meeting and National Congress of the Mexican Chapter of the International

Medical Marijuana, Inc Major Investment AXIM Biotech Enters Agreement With Israel-Based CRO To Begin Clinical POC Study For Treatment Of Restless Leg Syndrome

July 27, 2017

general-hemp-blog-images-11-16-16-ver1

SAN DIEGO, July 27, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its major investment AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC: AXIM) has entered into a Services Agreement with an Israel-based contract research organization (CRO)

AXIM Biotech Enters Services Agreement With Israel-Based CRO to Begin Clinical POC Study on CBD and Gabapentin Chewing Gum for Treatment of Restless Leg Syndrome

July 21, 2017

general-hemp-blog-images-11-16-16-ver1

AXIM Biotechnologies, Inc. (AXIM Biotech) AXIM, +2.42% a world leader in cannabinoid research and development, today announced that it has entered into a Services Agreement with an Israel-based contract research organization (CRO) to begin a clinical proof of concept study (POC) with its cannabidiol

Amyotrophic Lateral Sclerosis (ALS) and Psoriasis Patients Receive Brazilian Government Permission to Be Treated with Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil, Flagship Product RSHO™

July 19, 2017

general_hemp_blog_images_03-01-17_ver1

SAN DIEGO, July 19, 2017 /PRNewswire/ — Medical Marijuana, Inc. (MJNA) is the first publicly traded cannabis company in the United States. Its subsidiary HempMeds® Brasil today announced that the Company’s hemp cannabidiol (CBD) oil product Real Scientific Hemp Oil™ [RSHO™] has been prescribed by doctors in the country for the treatment

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Exclusive Red Carpet Event in Orange County, CA

July 13, 2017

general-hemp-blog-blur-people-sitting-17-01-13-ver1

SAN DIEGO – JULY 13, 2017 – Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary Kannaway LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, is holding an exclusive Red Carpet Event in Orange County, California, this Saturday.

Medical Marijuana, Inc. Announces Largest Revenue Quarter and Sales Month in Company History, 269% Revenue Increase From Q2 2016

July 11, 2017

general-hemp-blog-tablet-with-chart-11-13-16-ver1

Medical Marijuana, Inc. Wholly Owned Subsidiary Kannaway Has Largest Sales Month in June Since Company Was Founded SAN DIEGO, July 11, 2017 /PRNewswire/ – Medical Marijuana, Inc.(OTC:MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the second

Kannalife Sciences Participates in 27th Annual International Cannabinoid Research Society (ICRS) Symposium

July 6, 2017

general-hemp-blog-images-12-08-16-ver1

Company Presents Science Behind Mechanism of Action of CBD and its Own Patented CBD-derived Molecule KLS-13019 NEW YORK, July 5, 2017 /PRNewswire/ — Kannalife Sciences, Inc. (“Kannalife”), a bio-pharmaceutical and phyto-medical company, announced today that it presented its findings at the 27th Annual ICRS Symposium on

Forbes, Bloomberg, Global Press Cover Medical Marijuana, Inc. Subsidiary HempMeds® Mexico First Office Opening in Monterrey, Mexico

July 6, 2017

general-hemp-blog-images-01-30-17-ver1

Coverage Also Highlights Company’s Appointment of Renowned Medical Cannabis Advocate and Por Grace Foundation Founder Raul Elizalde as President SAN DIEGO, July 6, 2017 — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Mexico received international

Medical Marijuana, Inc. Subsidiary Dixie Botanicals™ Appoints New Director of Sales and Marketing Brent Albin

July 5, 2017

_dixie_blog_image_07-05-17-ver2

SAN DIEGO, July 3, 2017 — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary Dixie Botanicals™, one of the most recognizable cannabis brands in the world, has appointed Brent Albin as Director of Sales and Marketing. Medical Marijuana, Inc. Subsidiary Dixie Botanicals™ Appoints New